Know the numbers to calculate a plan…
When a patient is experiencing symptoms of preterm labour, it is important to determine if her risk of preterm birth is real or in contrast perhaps quite low.¹
Quantitative fetal fibronectin testing (Rapid fFN® Test) detects concentration levels of the fFN protein to reliably indicate whether a woman is likely to give birth prematurely.²
fFN acts as an adhesive glycoprotein at the maternal-fetal interface that bonds maternal membranes to fetal membranes.
It is a biomarker for preterm delivery and is highly associated with the risk of preterm delivery when present in cervicovaginal secretions.
fFN testing is the only named biomarker test recommended by the NICE clinical guidelines for the risk assessment of preterm labour & birth. ² ³
More information and less guesswork, to better predict the likelihood of preterm birth, ensuring enhanced peace of mind for the mother and healthcare professionals.
For further information on the advances of fFN testing and how it could be incorporated into your practices, please get in touch with your Hologic UK representative, by clicking the below button. Alternatively, visit our Healthcare Professionals Frequently Asked Questions where you can find further information on some of our most popular topics.
References
- AW-19098-002_003 – 10Q Cassette Product Insert
- National Institute for Health and Care Excellence (NICE). Diagnostic consultation document. March 2018. Available at: NICE Diagnostics Consultation Document
- National Institute for Health and Care Excellence (NICE). Preterm labour and birth guidance. Published November 2015. Available at: NICE Diagnosing Preterm Labour